HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.

Abstract
Although there are no randomized, controlled trials evaluating the efficacy of endoscopic retrograde cholangiography (ERC) in primary sclerosing cholangitis (PSC) patients, substantial indirect evidence supports the effectiveness of ERC in symptomatic PSC patients with a dominant stricture. Currently, cumulative evidence supports the role of ERC with endoscopic dilation with or without additional short-term stent placement for symptomatic PSC patients with a dominant stricture. Differentiating benign dominant strictures from cholangiocarcinoma (CCA) remains difficult; however, newer endoscopic techniques and advanced cytologic techniques are likely to improve sensitivity for the diagnosis of CCA over that achieved by traditional cytology brushing alone.
AuthorsNirav Thosani, Subhas Banerjee
JournalClinics in liver disease (Clin Liver Dis) Vol. 18 Issue 4 Pg. 899-911 (Nov 2014) ISSN: 1557-8224 [Electronic] United States
PMID25438290 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Topics
  • Bile Ducts, Intrahepatic (diagnostic imaging, pathology, surgery)
  • Cholangiopancreatography, Endoscopic Retrograde (methods)
  • Cholangitis, Sclerosing (diagnostic imaging, pathology, surgery)
  • Humans
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: